The StimOxyGen team receive funding from Innovate UK and CRUK to participate in the ICURe programme!
The StimOxyGen team based at the School of Pharmacy and Pharmaceutical Sciences, Ulster University, Northern Ireland, has secured funding to explore the commercial potential of is proprietary stimulus-responsive, oxygen-generating nanotechnology-based platform.
Funded by Innovate UK and Cancer Research UK, the team is participating in the Innovation to Commercialisation of University Research (ICURe) programme. ICURe realises that the translation of research from laboratories to industry is extremely time consuming, risky and expensive. The programme is their way of offering support for academic teams to explore the commercial potential of their research and strengthen links with Industry.
Over the next four months, Sian Farrell, as the Early Career Researcher and project lead, will contact potential key partners and customers in order to identify general commercial and stakeholder interest in the technology, identify and tackle potential challenges to commercial development at an early stage with a view towards providing a framework that will essentially shape a business route to commercial exploitation.
Watch this space!